Tuesday, 2 July 2013

Study Evidence Supports New Drug to Prevent Blood Clotting

The drug Eliquis (apixaban) is a new anticoagulant option that is at least as effective as other current blood thinners and possibly better at reducing rates of major bleeding, according to a recent trial. Eliquis, an oral direct Factor Xa inhibitor developed by Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE), was recently used in a six-month AMPLIFY trial. By inhibiting a key protein that clots blood, Eliquis prevents thrombin and blood clot formation. Acute venous thromboembolism (VTE) is a blood clot that forms within a vein, usually in the leg... via Health News from Medical News Today Read More Here..


Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/07/study-evidence-supports-new-drug-to_2.html

No comments:

Post a Comment